Advancing p53 Screening and Beyond
Unlock the full potential of your immuno-oncology drug development with Sengenics protein microarrays, featuring correctly folded proteins for clinically relevant results. Our ready-to use panels enable comprehensive screening of therapeutic antibodies and protein-binding compounds:
i-Ome® Cancer: Test drug target specificity and off-target reactivity with an array of 500+ protein antigens, meticulously selected for their significance in cancer.
OncoRex p53 Cancer Array: Gain precise insights into drug-p53 interactions with an array of 100+ wildtype and mutant p53 proteins, utilizing p53-DNA binding as a functional readout.
i-Ome® Discovery: Screen your drug with Sengenics’s largest protein microarray, compromising 1800+ human proteins representing diverse protein functions and disease categories.
